SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-583808
Filing Date
2016-05-09
Accepted
2016-05-09 16:08:19
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d169670d10q.htm 10-Q 523674
2 EX-31.1 d169670dex311.htm EX-31.1 5986
3 EX-31.2 d169670dex312.htm EX-31.2 5998
4 EX-32.1 d169670dex321.htm EX-32.1 3376
5 EX-32.2 d169670dex322.htm EX-32.2 3417
  Complete submission text file 0001193125-16-583808.txt   2570172

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20160331.xml EX-101.INS 395446
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20160331.xsd EX-101.SCH 31728
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20160331_cal.xml EX-101.CAL 44827
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20160331_def.xml EX-101.DEF 102870
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20160331_lab.xml EX-101.LAB 277580
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20160331_pre.xml EX-101.PRE 187236
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 161631706
SIC: 2834 Pharmaceutical Preparations